232 related articles for article (PubMed ID: 33960707)
1. Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models.
Feng B; Dong Z; Wang Y; Yan G; Yang E; Cheng H; Liang C; Hao Z; Zhang X; Song Z; Jiang Z; Chen M; Yue Z; Wang Z
Andrology; 2021 Sep; 9(5):1593-1602. PubMed ID: 33960707
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal shock wave therapy decreases COX-2 by inhibiting TLR4-NFκB pathway in a prostatitis rat model.
Jeon SH; Zhu GQ; Kwon EB; Lee KW; Cho HJ; Ha US; Hong SH; Lee JY; Bae WJ; Kim SW
Prostate; 2019 Sep; 79(13):1498-1504. PubMed ID: 31376214
[TBL] [Abstract][Full Text] [Related]
3. Effect of alcohol on chronic pelvic pain and prostatic inflammation in a mouse model of experimental autoimmune prostatitis.
Zhang LG; Chen J; Meng JL; Zhang Y; Liu Y; Zhan CS; Chen XG; Zhang L; Liang CZ
Prostate; 2019 Sep; 79(12):1439-1449. PubMed ID: 31233226
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.
Song Z; Jin C; Bian Z; Liang C
Mol Cell Biochem; 2021 Apr; 476(4):1905-1913. PubMed ID: 33492609
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
Hua X; Zhang J; Chen J; Feng R; Zhang L; Chen X; Jiang Q; Yang C; Liang C
Prostate; 2024 May; 84(7):666-681. PubMed ID: 38444115
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis.
Yuan P; Ma D; Zhang Y; Gao X; Liu Z; Li R; Wang T; Wang S; Liu J; Liu X
Neurourol Urodyn; 2019 Aug; 38(6):1457-1466. PubMed ID: 31037757
[TBL] [Abstract][Full Text] [Related]
7. Effect of Eriocalyxin B on prostatic inflammation and pelvic pain in a mouse model of experimental autoimmune prostatitis.
Zhang LG; Yu ZQ; Yang C; Chen J; Zhan CS; Chen XG; Zhang L; Hao ZY; Liang CZ
Prostate; 2020 Dec; 80(16):1394-1404. PubMed ID: 32965686
[TBL] [Abstract][Full Text] [Related]
8. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats.
Zhao Q; Yang F; Meng L; Chen D; Wang M; Lu X; Chen D; Jiang Y; Xing N
Andrology; 2020 May; 8(3):747-755. PubMed ID: 31880092
[TBL] [Abstract][Full Text] [Related]
9. Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results.
Bian Z; Jin C; Mo F; Zhang S; Meng J; Zhang M; Zhang L; Chen X; Hao Z; Song Z; Liang C
Andrologia; 2022 Oct; 54(9):e14490. PubMed ID: 35671994
[TBL] [Abstract][Full Text] [Related]
10. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
[TBL] [Abstract][Full Text] [Related]
11. [Role of mast cells in experimental autoimmune prostatitis in rats].
Zheng MX; Fan SC; Hua SQ; Luo Y; Cui QP; Liu XD
Zhonghua Nan Ke Xue; 2017 May; 23(5):399-405. PubMed ID: 29717828
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 deficiency attenuates inflammation and oxidative stress in experimental autoimmune prostatitis in a TLR4-dependent manner.
Fu X; He HD; Li CJ; Li N; Jiang SY; Ge HW; Wang R; Wang XL
Kaohsiung J Med Sci; 2020 Sep; 36(9):712-720. PubMed ID: 32436368
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal Shockwave Therapy Alleviates Inflammatory Pain by Down-Regulating NLRP3 Inflammasome in Experimental Chronic Prostatitis and Chronic Pelvic Pain Syndrome.
Bae WJ; Shin D; Piao JJ; Kim S; Choi YS; Park BH; Jung HJ; Sorkhi S; Chawla S; Cheon CW; Kang DU; Choi JT; Park SH; Kim SW; Rajasekaran MR
World J Mens Health; 2024 Jan; 42(1):157-167. PubMed ID: 37382279
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients.
Sokmen D; Comez YI
Aging Male; 2023 Dec; 26(1):2253876. PubMed ID: 37671978
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model.
Chen J; Zhang LG; Du HX; Zhan CS; Liu Y; Zhang M; Chen XG; Wen LP; Zhang L; Liang CZ
Prostate; 2021 Nov; 81(15):1179-1190. PubMed ID: 34418127
[TBL] [Abstract][Full Text] [Related]
16. Molecular Effects of Low-Intensity Shock Wave Therapy on L6 Dorsal Root Ganglion/Spinal Cord and Blood Oxygenation Level-Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Changes in Capsaicin-Induced Prostatitis Rat Models.
Wang HJ; Su CH; Chen YM; Yu CC; Chuang YC
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563108
[TBL] [Abstract][Full Text] [Related]
17. CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation.
Hua X; Zhang J; Ge S; Liu H; Du H; Niu Q; Chen X; Yang C; Zhang L; Liang C
Prostate; 2022 Sep; 82(13):1223-1236. PubMed ID: 35700340
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.
Kong X; Hu W; Dong Z; Tian J; Wang Y; Jin C; Liang C; Hao Z; Wang Z
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):483-494. PubMed ID: 35798855
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients.
Sokmen D; Comez YI
Urol Int; 2023; 107(9):872-876. PubMed ID: 37611558
[TBL] [Abstract][Full Text] [Related]
20. Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
Kurita M; Yamaguchi H; Okamoto K; Kotera T; Oka M
Prostate; 2018 Nov; 78(15):1157-1165. PubMed ID: 30009466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
